LEWES, Del., Oct. 1, 2025 /PRNewswire/ — Neteera Technologies Ltd. today announced results from a clinical study demonstrating that its contactless monitoring system achieved 77% sensitivity in detecting impending hospitalizations among nursing facility residents, providing a warning of 4.99 days on average for clinical intervention.
The comprehensive, retrospective study, conducted in partnership with TapestryHealth across five nursing facilities over a four-month period, monitored 612 residents and analyzed 96 hospitalization events. The results provide healthcare facilities with clinical evidence that Neteera’s FDA-cleared vital sign monitoring sensor technology can provide early warnings that may help care teams reduce avoidable hospitalizations through timely intervention.
Key Clinical Results:
“This clinical evidence validates that Neteera’s technology can help care teams identify at-risk patients earlier to reduce avoidable hospitalizations while improving patient care,” said Isaac Litman, CEO of Neteera. “Clinical teams equipped with early warning alerts can intervene proactively, transforming emergency responses into treat-in-place care.”
The Neteera System utilizes ambient sensor technology to detect micro-movements from cardiac and respiratory activity through clothing and bedding, eliminating the need for wearable devices, cameras, or direct patient contact. By continuously tracking heart rate and respiratory rate, the system uses proprietary, AI-powered algorithms to analyze deviations from each patient’s baseline and alert when these deviations exceed the threshold.
“Early identification of patient deterioration fundamentally changes care delivery from reactive to proactive,” said Dr. Hans Jenkins, Chief Medical Officer at TapestryHealth. “When clinical teams receive alerts five days before emergency hospitalization becomes necessary, they can initiate targeted treatments and often resolve underlying conditions without hospital admission.”
About the Study: The retrospective analysis was conducted from November 2024 to February 2025, led by Dr. Shai Shechter and Dr. Alex Kazakov from Neteera. All patient data were handled in compliance with applicable privacy regulations and relevant data use agreements. The full study methodology and statistical analysis are available for download.
About TapestryHealth: TapestryHealth delivers technology solutions supporting clinical care delivery and patient monitoring in healthcare facilities. Visit tapestryhealth.com.
About Neteera: Neteera develops contactless sensing solutions using proprietary micro-radar technology to deliver real-time patient insights in healthcare settings. The system continuously measures vital signs without the need for wearables, cameras, or microphones. Visit neteera.com.
SOURCE Neteera
Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to…
Telehealth Platform Facilitates Compounded Semaglutide and Tirzepatide Access Through Licensed Provider Evaluation as FDA Shortage…
Analysis examines best peptides for boosting growth hormone as ReadyRx lists prescription sermorelin in injectable…
Discover the best fat burner for men in 2025. Explore Wolfson Brand’s effective fat-burning supplements…
Industry Analysis Examines How Cost, Safety, and Access Considerations Shape Semaglutide Choices as MEDVi Lists…
Deploying “Proof of Human” Infrastructure throughout Japan, a Technology Envisioned by Sam Altman and Alex…